摘要：默克与腾讯签署协议，默克在科技领域的专业优势以及腾讯在互联网和人工智能领域的前沿技术，聚焦于在中国通过数字化平台提高公众对疾病的认识，提供更具可及性的医疗服务。
Merck & Co., Inc. (MRK) on Wednesday signed a strategic collaboration agreement today with Tencent Holdings Ltd. (TCEHY.PK), a provider of Internet value added services in China. The collaboration will primarily focus on increasing public disease awareness and providing more accessible healthcare services via digital platforms in China.
默克公司( Merck & Co ., Inc .)周三与中国互联网增值服务提供商腾讯控股有限公司( Tencent Holdings Ltd .)签署了战略合作协议。此次合作的主要重点是提高公众对疾病的认识，并通过中国的数字平台提供更多可获得的医疗服务。
With the agreement, Merck and Tencent will create intelligent digital healthcare services, thereby increasing public knowledge of diseases and improving patients' understanding of disease symptoms and effective treatment options to better manage chronic diseases.
根据协议，默沙东和腾讯将打造智能数字医疗服务，从而提高公众对疾病的认识，提高患者对疾病症状的理解和有效的治疗选择，以更好地管理慢性病。
The focus areas will include all treatment areas of Merck's Healthcare business in China such as allergies, infertility, diabetes, thyroid disorders and cardiovascular diseases, as well as oncology such as metastatic colorectal cancer (mCRC).
重点领域将包括默克公司在中国的医疗保健业务的所有治疗领域，如过敏、不孕症、糖尿病、甲状腺疾病和心血管疾病，以及转移性结直肠癌（ mCRC ）等肿瘤。
本文未完，阅读全文请访问www.investank.com
